Possibia

199095

Last Update Posted: 2023-03-20

Recruiting has ended

All Genders

accepted

65 Years +

40 Estimated Participants

No Expanded Access

Interventional Study

Does not accept healthy volunteers

Treatment of Elderly Patients (>65 Years) With Acute Lymphoblastic Leukemia

The aim of this study is to test feasibility and efficacy of a dose reduced chemotherapy in elderly patients with newly diagnosed acute lymphoblastic leukemia. The regimen consists of induction phase I and II followed by cyclic consolidation cycles, reinduction and maintenance therapy

Eligibility

Relevant conditions:

Adult Acute Lymphocytic Leukemia

If you aren't sure if you meet the criteria above speak to your healthcare professional. Criteria may be updated but not reflected here, do not hesitate to contact the trial if you think are close to fitting criteria.

locations

Contact Information

Overall Contact

No valid contacts available

Data sourced from ClinicalTrials.gov